Article
YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
Journal of gastroenterology and hepatology - 1 Jan 2013
Eurich Dennis, Neumann Ulf P, Boas-Knoop Sabine, Neuhaus Ruth, Kiessling Anja, Yahyazadeh Ali, Trautwein Christian, Wasmuth Hermann, Puhl Gero, Neuhaus Peter, Bahra Marcus
Abstract excerpt
BACKGROUND AND AIM: The development of end-stage graft disease is suspected to be partially determined by an individual genetic background. The aim of our study was to determine the prevalence of YKL-40-gene polymorphism in hepatitis C virus (HCV)-positive patients and its impact on the incidence of acute cellular rejection (ACR), graft fibrosis and antiviral treatment response. METHODS: A total of 149 patients,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
